Transgender people are disproportionally impacted by HIV globally, yet are underrepresented in clinical HIV prevention trials. Beyond safety and efficacy data, there is also a need for implementation research and strong stakeholder engagement programs that address the needs of the community. On the webinar, experts will outline the research gaps on transgender issues and preview a roadmap that will be featured at HIV Research for Prevention.
Join us to hear from two experts, Max Appenroth and Immaculate Mugo, who will be presenting a proposed research pipeline at HIV R4P. The two leaders will talk to us about the current gaps and preview the road forward!